Pfizer Inc.
New York, New York, United States
Purpose
to support development of a Group B streptococcus (GBS) vaccine for developing country access
Division
Global Health
Date
September 2016
Region Served
AFRICA, AMERICA, ASIA
Committed amount
$17,252,854
Grant topic
Pneumonia & Pandemic Preparedness, Research and Learning Opportunities
Duration (months)
99
Grantee location
New York, New York, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.